WCM
LLY icon

Wallace Capital Management’s Eli Lilly LLY Stock Holding History

Wallace Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$428K Sell
465
-10
-2% -$10.1K 0.05% 52
2025
Q4 		$510K Sell
475
-180
-27% -$172K 0.06% 48
2025
Q3 		$500K Sell
655
-15
-2% -$11.2K 0.06% 51
2025
Q2 		$522K Hold
670
– – 0.07% 49
2025
Q1 		$553K Sell
670
-335
-33% -$279K 0.07% 49
2024
Q4 		$776K Sell
1,005
-125
-11% -$104K 0.11% 43
2024
Q3 		$1M Buy
1,130
+100
+10% +$89.9K 0.14% 42
2024
Q2 		$933K Sell
1,030
-200
-16% -$160K 0.14% 43
2024
Q1 		$957K Sell
1,230
-162
-12% -$115K 0.13% 43
2023
Q4 		$811K Sell
1,392
-540
-28% -$315K 0.12% 44
2023
Q3 		$1.04M Sell
1,932
-374
-16% -$193K 0.16% 41
2023
Q2 		$1.08M Sell
2,306
-200
-8% -$83.9K 0.17% 45
2023
Q1 		$861K Sell
2,506
-25
-1% -$8.43K 0.14% 42
2022
Q4 		$926K Buy
2,531
+925
+58% +$328K 0.15% 44
2022
Q3 		$519K Hold
1,606
– – 0.09% 46
2022
Q2 		$510K Sell
1,606
-97
-6% -$29.1K 0.08% 51
2022
Q1 		$493K Hold
1,703
– – 0.07% 50
2021
Q4 		$470K Buy
1,703
+173
+11% +$43.9K 0.07% 49
2021
Q3 		$354K Sell
1,530
-71
-4% -$17.5K 0.05% 57
2021
Q2 		$367K Hold
1,601
– – 0.05% 52
2021
Q1 		$298K Hold
1,601
– – 0.04% 58
2020
Q4 		$270K Hold
1,601
– – 0.04% 59
2020
Q3 		$237K Sell
1,601
-167
-9% -$25.8K 0.04% 61
2020
Q2 		$290K Hold
1,768
– – 0.05% 52
2020
Q1 		$245K Hold
1,768
– – 0.05% 52
2019
Q4 		$232K Sell
1,768
-3,676
-68% -$426K 0.03% 56
2019
Q3 		$609K Hold
5,444
– – 0.08% 46
2019
Q2 		$603K Buy
5,444
+28
+0.5% +$3.3K 0.08% 46
2019
Q1 		$703K Sell
5,416
-379
-7% -$46.1K 0.1% 42
2018
Q4 		$671K Hold
5,795
– – 0.1% 44
2018
Q3 		$622K Hold
5,795
– – 0.08% 48
2018
Q2 		$494K Hold
5,795
– – 0.07% 56
2018
Q1 		$448K Buy
5,795
+150
+3% +$12.1K 0.06% 56
2017
Q4 		$477K Hold
5,645
– – 0.07% 57
2017
Q3 		$483K Hold
5,645
– – 0.08% 53
2017
Q2 		$465K Hold
5,645
– – 0.07% 54
2017
Q1 		$475K Sell
5,645
-200
-3% -$16K 0.08% 54
2016
Q4 		$430K Sell
5,845
-174
-3% -$13K 0.08% 55
2016
Q3 		$484K Sell
6,019
-34
-0.6% -$2.72K 0.09% 51
2016
Q2 		$477K Hold
6,053
– – 0.08% 49
2016
Q1 		$436K Sell
6,053
-1,000
-14% -$75.7K 0.08% 44
2015
Q4 		$594K Buy
7,053
+174
+3% +$14.4K 0.11% 42
2015
Q3 		$576K Hold
6,879
– – 0.11% 45
2015
Q2 		$574K Hold
6,879
– – 0.1% 43
2015
Q1 		$500K Buy
+6,879
New +$490K 0.09% 45
2014
Q3 		– Sell
-6,129
Closed -$381K – 54
2014
Q2 		$381K Buy
+6,129
New +$366K 0.08% 48
2013
Q4 		– Sell
-6,129
Closed -$308K – 65
2013
Q3 		$308K Hold
6,129
– – 0.08% 58
2013
Q2 		$301K Buy
+6,129
New +$333K 0.09% 58

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wallace Capital Management's LLY Position: Q1 2026 in Review

Wallace Capital Management reduced its Eli Lilly (LLY) stake by 2.1% in Q1 2026, selling an estimated $10.1K and leaving 465 shares worth $428K. The position accounts for 0.05% of the portfolio, ranked #52.

Wallace Capital Management first reported a position in LLY in Q2 2013 and has held it in 48 quarters since. The position peaked at $1.08M in Q2 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wallace Capital Management held 465 shares of Eli Lilly worth $428K as of Q1 2026.
  • Wallace Capital Management sold 10 Eli Lilly shares in Q1 2026, an estimated $10.1K.
  • Eli Lilly made up 0.05% of Wallace Capital Management's portfolio in Q1 2026, its #52 holding.
  • Wallace Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 48 quarters since.
  • Wallace Capital Management's Eli Lilly position peaked at $1.08M in Q2 2023.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wallace Capital Management's 13F filing for Q1 2026, filed 15 May 2026.